Purchase Order HHSF223201410295A
- Not listed
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Qiagen, LLC, a subsidiary of the biotechnology company Qiagen N.V. The $5,677.65 contract is for a QIAGILITY SERVICE AGREEMENT and does not have a set-aside designation. Qiagen, a global provider of sample and assay technologies, has a history of federal contract awards and blanket purchase agreements to supply products and services in support of biomedical research, public health, law enforcement, and...
- This is a $147,859.57 firm fixed-price delivery order issued under the Qiagen IDIQ contract (75F40121D00009) by the Food and Drug Administration (FDA), a civilian federal agency. The order is for the purchase of molecular biology reagents, with no set-aside designation. The prime contractor is Qiagen, LLC, a foreign-owned, for-profit manufacturer and global provider of sample and assay technologies for molecular diagnostics, applied testing, pharmaceuticals, and academic research. Qiagen, LLC is...
- This is a $211,853.58 firm fixed-price purchase order awarded by the Defense Health Agency to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, laboratory equipment, and bioinformatics software. The contract is for QCII ONE PRECUR 301-600 TESTING, with a period of performance through May 31, 2027. Qiagen, LLC is a subsidiary of the multinational biotechnology company Qiagen N.V., which has a significant federal contract portfolio supporting biomedical research,...
- This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and laboratory equipment. The $11,333.80 contract is for the delivery of specialized products and services, including DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, sample preparation instruments, precision medicine analysis tools, and bioinformatics software. Qiagen...
- This is a federal contract award (75N90025P00400) issued by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a foreign-owned for-profit manufacturer of molecular diagnostic and life sciences products. The contract, valued at $30,071.70, is for a 12-month period of performance and includes the provision of Qiagen's QIAGILITY and QIASYMPHONY SP instruments and associated maintenance services. The contract is not associated with a set-aside program. Qiagen has previously been...
- This is a $12,060 firm-fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and scientific equipment. The contract is for maintenance services on Qiagen's EZ2 Connect and QIAcuity One instruments used for isolation and analysis of cell-free DNA. The contract has an ultimate completion date of August 15, 2026. Qiagen has established itself as a critical...
- This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 1 (VISN 1), a division of the U.S. Department of Veterans Affairs, to Qiagen, LLC, a foreign-owned manufacturer of molecular diagnostics and laboratory equipment. The $19,194 contract provides for the service and maintenance of QIAGEN equipment over a period ending on July 19, 2026. Qiagen is an experienced federal contractor, holding several multi-million dollar Indefinite Delivery Vehicles (IDVs)...
- This federal contract award was made by a civilian federal agency to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract is for the purchase of scientific consumables, such as DNA/RNA extraction kits, next-generation sequencing equipment, and bioinformatics software, with a ceiling value of $6,162.64. The contract is a firm fixed-price purchase order without a set-aside designation, indicating Qiagen's ability to compete effectively in the federal...
- This federal contract award was made by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics, scientific equipment, and bioinformatics solutions. The $12,332.71 firm fixed-price purchase order is for the delivery of Qiagen's products and services, which likely include DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, sample preparation instruments, precision medicine analysis...
- This is a $10,768 firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Qiagen, LLC, a division of the international biotechnology company Qiagen N.V. The contract is for the provision of Qiagen's clinical insight analysis products and services, with a period of performance through September 28, 2026. Qiagen, a foreign-owned, for-profit manufacturer, specializes in molecular diagnostics, scientific equipment, and bioinformatics solutions. The...
This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics and life science products. The contract, valued at $3,784.00, is for the annual maintenance plan of a QIAGILITY instrument. The contract does not have a set-aside designation. Qiagen, LLC is a subsidiary of the multinational biotechnology company Qiagen N.V., which has a significant federal contract portfolio spanning agencies such as the National Institutes of Health, Centers for Disease Control and Prevention, Department of Veterans Affairs, and Department of Justice. Qiagen provides a wide range of products and services to support federal research, public health, and healthcare initiatives, including DNA/RNA extraction kits, next-generation sequencing equipment, digital PCR systems, sample preparation instruments, and bioinformatics software.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 9/8/14 |